Status:
COMPLETED
Age of Red Blood Cells in Premature Infants Study (ARIPI)
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Premature Birth
Eligibility:
All Genders
1-37 years
Phase:
NA
Brief Summary
To determine if the age of blood transfused to new borns in the NICU setting has an impact on their outcome.
Eligibility Criteria
Inclusion
- birthweight of less than 1250g
- admitted to participating NICU
- consent acquired from proxy for the patient
Exclusion
- already received one or more transfusions
- requirement for an exchange transfusion
- will be receiving directed donations
- have rare blood types/difficult cross-match
- proxy has refused consent
- moribund on admission to NICU/expected to die
- mitigating child protection issues
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
377 Patients enrolled
Trial Details
Trial ID
NCT00326924
Start Date
May 1 2006
End Date
June 1 2012
Last Update
January 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6